EVALYNE MWANGI: Open Payments
NPI 1265203061 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $60 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $133 |
| Gilead Sciences, Inc. | 1 | $123 |
Products named: INGREZZA.
Industry payments across DE — which companies pay providers there.
